Transforming the lives of millions of patients by investing in groundbreaking medical innovations.

Endeavour Vision is a leading private equity firm exclusively investing in medical technology. This singular focus requires deep sector knowledge and experience, so our team is made up of industry veterans and investment professionals who are experts in the medtech sector. Our specialities include accelerating company growth and product launches with a proven track records of successful exits.

We invest in growth stage companies with world class technology and products. These innovations address an unmet clinical need and hold the potential to significantly improve and extend the lives of patients around the world.

Our Values

supporting life changing ideas

Supporting Life Changing Ideas

We believe that innovations in medical technology can significantly improve the standard of care for millions of people, while reducing healthcare costs.

We want to make a meaningful impact through our work and seek partners that share our vision.

icon medtech

Medtech Experts

Medtech investment is an area that requires deep sector knowledge and experience. 

As our business focuses exclusively on medical technology, we have extensive industry knowledge and several team members have built successful medtech companies. We thrive on creating, developing and exiting best-in-class medtech companies, in the US and Europe.

Adding Value

Adding Value

Investments are about more than just capital, we believe in getting our hands dirty and guiding entrepreneurs through strategic decisions and challenges, to help them build great companies.

We leverage our integral network of industry insiders to establish trends, define unmet medical needs and build strong investor syndicates.

Testimonials

View Companies

“As a trusted Board Member and Partner, Endeavour Vision brings a wealth of operational and financial experience to the team. They are interested in building companies the right way and creating a foundation for long-term accelerated growth, through a collaborative and detailed approach. Endeavour has always been a positive influence on our company and market. They are not only interested in representing transformational technologies but ensuring those technologies bring significant benefit to patients across the globe.”

Christopher M. OwensChristopher M. Owens, President & CEO, Gynesonics

“As the founding investor in CeQur, Endeavour Vision has been a great partner over the years, providing strategic input, on-going support and novel financing. The Endeavour Board Members bring a wealth of experience in R&D management, organizational management, marketing, regulatory affairs, clinical evaluation, and quality thus providing a resource for the CeQur management team to leverage as we work towards developing a successful product that will help thousands of patients with T2 diabetes achieve better glycemic control.”

Robert FarraRobert Farra, former CEO, CeQur Corporation
“We find in Endeavour Vision a unique and highly-sophisticated team, which adds significant value to our commercialization ramp-up. This includes strategic input, organizational development and talent acquisition. They’re an investment tteam which works closely with management to identify creative solutions to complex issues, leading the maximum value creation for the enterprise. I highly recommend Endeavour Vision as a valuable venture partner.”
Earl FenderEarl R.Fender, President & CEO, Vertiflex

“Chrono Therapeutics has been very pleased and impressed with Endeavour Vision medical product experience and domain knowledge. They have been engaged, supportive, thoughtful partners, particularly in the areas of regulatory strategy and product development.”

Alan LevyAlan Levy, former CEO, Chrono Therapeutics

“Endeavour Vision’s team brought an in-depth knowledge of our field – highlighted by impressive and thorough 360˚ due diligence, the long-term perspective required to build substantial companies, outstanding experience of bringing venture to financial success and an uncommon sense for team work. This is “smart money” at its best.”

Jaques R. Essinger, former CEO, Symetis

Looking to raise funds for your business? Take a look at our Financing Page.

View Page